Biogen · 8 hours ago
Intern, Health Equity & Clinical Innovation, Rural Community Engagement
Biogen is a mid-sized biotechnology company committed to health equity and clinical innovation. They are seeking an intern to support initiatives focused on rural communities, providing exposure to medical affairs that integrate health equity principles into various strategic areas.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Conduct research on rural health disparities relevant to priority disease areas, including:
Diagnostic and care deserts
Coverage and access barriers
Barriers to clinical research participation and real-world care
Synthesize insights to inform medical affairs disease strategy, evidence gaps, and scientific priorities
Support development of a rural health equity engagement framework aligned with Biogen’s medical affairs and health equity objectives
Support medical affairs led evidence development by identifying gaps related to rural and underserved populations
Translate qualitative community insights into scientifically relevant considerations for medical affairs teams
Support medical affairs aligned community outreach initiatives with:
Community clinics and health systems
Local advocacy organizations
Trusted community stakeholders
Assist in planning and participating in community engagement activities to gather medical and scientific insights
Document and synthesize feedback to inform medical affairs strategy and evidence planning
Support development of scientifically accurate, culturally appropriate educational materials for rural audiences
Contribute to disease awareness and clinical research education efforts consistent with medical affairs standards
Collaborate with internal medical affairs partners to ensure rural health equity insights are reflected in broader scientific initiatives
Complete at least one Health Equity Disease Literature and Insights Overviews aligned with medical affairs standards, including:
Epidemiology and disease burden
Demographic and geographic variation
Severity, comorbidities, and outcomes
Economic burden and access challenges, diagnostic delay
Racial/ethnic, age, and gender differences
Quality of life and caregiver impact
Published patient reported outcomes, patient experience and real-world data
Present findings including opportunities for Biogen medical teams to medical affairs and Health Equity team members at the conclusion of the internship
Support ad hoc medical affairs or Health Equity projects as needed
Contribute to synthesis decks, briefing documents, and insight summaries for internal stakeholders
Qualification
Required
Strong interest in medical affairs, health equity, pharmaceutical development, rural health, public health, or clinical research
Excellent written and verbal communication skills with demonstrated cultural humility
Experience conducting literature reviews using PubMed, Embase, or similar databases
Ability to synthesize scientific, qualitative, and community-based insights into clear, actionable recommendations
Organized, proactive, and comfortable working independently in a large, matrixed environment
Legal authorization to work in the U.S
At least 18 years of age prior to the scheduled start date
Currently enrolled in an accredited community college, college, university or skills program/apprenticeship
Currently enrolled in a graduate (any year) or undergraduate (ideally rising senior) level program focused in: Medicine, nursing, pharmacy, public health, biology, clinical research, healthcare administration, health policy, or other healthcare related fields
Candidates from other majors such as communications, sociology, psychology, anthropology, public relations, or related disciplines with strong relevance to health equity and medical affairs will also be considered
Benefits
Company paid holidays
Commuter benefits
Employee Resource Groups participation
80 hours of sick time per calendar year
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Recent News
Company data provided by crunchbase